Expert consensus on the management of chronic lymphocytic leukaemia in Asia
In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL...
Saved in:
Main Author: | Tse E. |
---|---|
Other Authors: | Mahidol University |
Format: | Letter |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: Adaptation based on an expert consensus meeting
by: Chien Chang Lee, et al.
Published: (2020) -
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations
by: Ahn M.J.
Published: (2023) -
Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients
by: Chan, T.S.-Y, et al.
Published: (2020) -
Erratum: Procalcitonin (PCT)guided antibiotic stewardship in Asia-Pacific countries: Adaptation based on an expert consensus meeting. (Clin Chem Lab Med (2020) 58:12 (1983–91) Doi:10.1515/cclm-2019-1122)
by: Chien Chang Lee, et al.
Published: (2022) -
Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023
by: Kario K.
Published: (2023)